Capturing the Global Advantage Pharmaceutical Series: Emerging Growth Markets

In their quest to Capture the Global Advantage, Pharma companies face an ever-shifting industry landscape full of challenges and opportunities.

The Global Pharmaceutical Center can help pharma companies answer the question: What choices do pharma executives need make to establish a new equilibrium that balances risks and rewards, to avoid major pitfalls, and to grow their business globally?


Other Webcasts & Podcasts

The Obama administration and the new Congress:

Good medicine for the pharma, biotech, and medtech industries?

February 20, 2009

Drug and Medical Device Safety: Leveraging Customs for Product Safety (Podcast 4 of 4)

October 15, 2007

Drug and Medical Device Safety: Product Liability (Podcast 3 of 4)

October 1, 2007

Drug and Medical Device Safety: Data Analytics (Podcast 2 of 4)

September 17, 2007

Drug and Medical Device Safety: Product Safety Compliance (Podcast 1 of 4)

September 4, 2007

Capturing the Global Advantage Pharmaceutical Series: Stakeholder Confidence

June 28, 2007

Capturing the Global Advantage Pharmaceutical Series: Cross-Border Value Chains

May 24, 2007

Capturing the Global Advantage Pharmaceutical Series

January 19, 2007

image

Released on:
Thursday, June 28, 2007

(n/a
n/a your local time)

Duration: 12 minutes

Note: the webcast technology is not compatible with the browser you are using. Use Internet Explorer or Firefox.

Ernst & Young refers to one or more of the member firms of Ernst & Young Global Limited (EYG), a UK private company limited by guarantee. EYG is the principal governance entity of the global Ernst & Young organization and does not provide any services to clients. Services are provided by EYG member firms. Each of EYG and its member firms is a separate legal entity and has no liability for another such entity's acts or omissions. Certain content on this site may have been prepared by one or more EYG member firms.